|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2026
As of Dec 31, 2026
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts and other receivables (net of allowance for doubtful accounts of $858 and $918 respectively) | ||||||||||||||||||||
| Notes receivable - Vyome | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Accounts receivables, net | ||||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Non-current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Intangible asset - shell company | ||||||||||||||||||||
| Goods and service tax and other credits receivable | ||||||||||||||||||||
| Prepaid insurance- long term portion | ||||||||||||||||||||
| Right-of-use of asset, net | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued and other liabilities | ||||||||||||||||||||
| Warranty liability, current | ||||||||||||||||||||
| Debt, current portion | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Due to Affiliates | ||||||||||||||||||||
| Operating lease liability - current portion | ||||||||||||||||||||
| Salary and post-employment benefits payable | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Convertible debt - current portion | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Operating lease liability - net of current portion | ||||||||||||||||||||
| Common stock warrant liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Common stock, 300,000,000 VHI shares authorized, 7,018,528 and 5,919,337 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Preferred stock of VTI, 16,000,000 shares authorized, 0 and 3,076 shares issued and outstanding as of December 31, 2025 and 2024, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Non-controlling interest in VTI; 20,000,000 common shares authorized, 1,481,598 shares issued and outstanding at both June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total accumulated other comprehensive loss | ||||||||||||||||||||
| Equity attributable to shareowners of VHI | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
